Sihuan Pharma Sees Sales Boost From Expanded Access To Hospitals, Insurance Across Rural China
This article was originally published in The Pink Sheet Daily
“Explosion” in healthcare spending rooted in government reforms, new wealth, analyst says.
You may also be interested in...
China Set To Launch Sweeping Health System Reforms, Aimed In Part At Reversing Stratified Access To Medicine, Hospitals, Insurance
BEIJING - China's central government is set to launch sweeping reforms of the country's health system, with the ultimate goal of providing universal health care by the year 2020
BEIJING - In just one sign that the race for pharmaceutical patents is speeding up across China, an executive at Sihuan Pharmaceutical Holdings said the company has applied for hundreds of patents over the past two years
Bayer Schering Partners With Polish Biotech Firm To Provide Recombinant Insulin To China's Exploding Diabetics Population
Bayer's antidiabetes drug Glucobay (acarbose), an alpha-glucosidase inhibitor, is already one of the company's strongest products in China.